| Katherine Lynn Mcclanahan, DO | |
|
10624 S Eastern Ave # A-955, Henderson, NV 89052-2982 | |
| (702) 800-5393 | |
| Not Available |
| Full Name | Katherine Lynn Mcclanahan |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 10624 S Eastern Ave # A-955, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467425884 | NPI | - | NPPES |
| 100507178 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 20A7842 (California) | Secondary |
| 208M00000X | Hospitalist | 50707 (Colorado) | Secondary |
| 207R00000X | Internal Medicine | 1211 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Rose Dominican Hospitals - Siena Campus | Henderson, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Platinum Hospitalists Llp | 7214076322 | 173 |
News Archive
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces it has signed a lease to rent a 75,000-square-foot building in Lone Tree (Littleton), Colorado. Zynex currently leases 16,553 square feet in Littleton, Colorado and the new building will house its headquarters, office, plant and warehouse.
Whether it's the Ebola virus or Sarin and Ricin, a key to responding to chemical or biological attacks is having effective antidotes at the ready. To accelerate the development of new therapies, Wake Forest Baptist Medical Center's Institute for Regenerative Medicine is leading a unique $24 million federally funded project to develop a "body on a chip" that will be used to develop these countermeasures.
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Bayer HealthCare Pharmaceuticals, Inc. today announced that the study "Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study" was published online this week by the European Respiratory Journal. Results of this study to assess the safety, tolerability and the feasibility of individual dose titration of riociguat were previously presented at the 2009 International Conference of the American Thoracic Society.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, summarizes the history of G8 global health initiatives and examines why global health has been dropped from the G8 and G20 agendas, writing that "as we look to the U.S.-hosted G8 meeting in 2012, global health is still nowhere to be found."
› Verified 8 days ago
| Entity Name | Platinum Hospitalists Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861627242 PECOS PAC ID: 7214076322 Enrollment ID: O20091203000160 |
News Archive
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces it has signed a lease to rent a 75,000-square-foot building in Lone Tree (Littleton), Colorado. Zynex currently leases 16,553 square feet in Littleton, Colorado and the new building will house its headquarters, office, plant and warehouse.
Whether it's the Ebola virus or Sarin and Ricin, a key to responding to chemical or biological attacks is having effective antidotes at the ready. To accelerate the development of new therapies, Wake Forest Baptist Medical Center's Institute for Regenerative Medicine is leading a unique $24 million federally funded project to develop a "body on a chip" that will be used to develop these countermeasures.
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Bayer HealthCare Pharmaceuticals, Inc. today announced that the study "Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study" was published online this week by the European Respiratory Journal. Results of this study to assess the safety, tolerability and the feasibility of individual dose titration of riociguat were previously presented at the 2009 International Conference of the American Thoracic Society.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, summarizes the history of G8 global health initiatives and examines why global health has been dropped from the G8 and G20 agendas, writing that "as we look to the U.S.-hosted G8 meeting in 2012, global health is still nowhere to be found."
› Verified 8 days ago
| Entity Name | Bessler Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801288774 PECOS PAC ID: 1355660077 Enrollment ID: O20150430002704 |
News Archive
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces it has signed a lease to rent a 75,000-square-foot building in Lone Tree (Littleton), Colorado. Zynex currently leases 16,553 square feet in Littleton, Colorado and the new building will house its headquarters, office, plant and warehouse.
Whether it's the Ebola virus or Sarin and Ricin, a key to responding to chemical or biological attacks is having effective antidotes at the ready. To accelerate the development of new therapies, Wake Forest Baptist Medical Center's Institute for Regenerative Medicine is leading a unique $24 million federally funded project to develop a "body on a chip" that will be used to develop these countermeasures.
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Bayer HealthCare Pharmaceuticals, Inc. today announced that the study "Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study" was published online this week by the European Respiratory Journal. Results of this study to assess the safety, tolerability and the feasibility of individual dose titration of riociguat were previously presented at the 2009 International Conference of the American Thoracic Society.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, summarizes the history of G8 global health initiatives and examines why global health has been dropped from the G8 and G20 agendas, writing that "as we look to the U.S.-hosted G8 meeting in 2012, global health is still nowhere to be found."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Lynn Mcclanahan, DO P.o. Box 34046, Las Vegas, NV 89133-4046 Ph: (702) 787-7524 | Katherine Lynn Mcclanahan, DO 10624 S Eastern Ave # A-955, Henderson, NV 89052-2982 Ph: (702) 800-5393 |
News Archive
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces it has signed a lease to rent a 75,000-square-foot building in Lone Tree (Littleton), Colorado. Zynex currently leases 16,553 square feet in Littleton, Colorado and the new building will house its headquarters, office, plant and warehouse.
Whether it's the Ebola virus or Sarin and Ricin, a key to responding to chemical or biological attacks is having effective antidotes at the ready. To accelerate the development of new therapies, Wake Forest Baptist Medical Center's Institute for Regenerative Medicine is leading a unique $24 million federally funded project to develop a "body on a chip" that will be used to develop these countermeasures.
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Bayer HealthCare Pharmaceuticals, Inc. today announced that the study "Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study" was published online this week by the European Respiratory Journal. Results of this study to assess the safety, tolerability and the feasibility of individual dose titration of riociguat were previously presented at the 2009 International Conference of the American Thoracic Society.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, summarizes the history of G8 global health initiatives and examines why global health has been dropped from the G8 and G20 agendas, writing that "as we look to the U.S.-hosted G8 meeting in 2012, global health is still nowhere to be found."
› Verified 8 days ago
James B Gabroy, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1535 West Warm Spring Road, Suite 135, Henderson, NV 89014 Phone: 702-450-3385 Fax: 702-898-1699 | |
Dr. Poupak Ziaei, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2641 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-616-0091 Fax: 702-616-2329 | |
Dr. Jeannette Nee, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2865 Siena Heights Dr, Suite 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 | |
Wen Liang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2621 W Horizon Ridge Pkwy, Suite 150, Henderson, NV 89052 Phone: 702-837-6368 Fax: 702-837-0685 | |
Randy James Ip, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2865 Siena Heights Dr Ste 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 | |
Linda Lou Johnson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 W Sunset Rd, Henderson, NV 89014 Phone: 725-269-7001 Fax: 725-269-7003 | |
Dr. Daejoon Anh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2865 Siena Heights Dr Ste 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 |